Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
Key Highlights
- ➤Biodesix (BDSX) will report third-quarter 2026 results November 5 after market close
- ➤Management will host a 4:30 p.m. Eastern conference call and webcast November 5
- ➤Biodesix offers Nodify Lung and IQLung diagnostic tests for lung disease decisions
LOUISVILLE, Colo., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the third quarter ended September 30, 2026 after the close of trading on Thursday, November 5. Biodesix management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.
Listeners can register for the webcast via this link. Analysts who wish to participate in the question and answer session should use this link. A replay of the webcast will be available via the company’s investor website approximately two hours after the call’s conclusion. Participants are advised to join 15 minutes prior to the start time.
Get started
Create a free account to read the full story.